FINWIRES · TerminalLIVE
FINWIRES

Sichuan Biokin Pharmaceutical Secures Commitment for Share Repurchase Loan

By

Sichuan Biokin Pharmaceutical (SHA:688506) obtained a commitment letter for a 180 million yuan, three-year loan from Bank of China (HKG:3988, SHA:601988) for its share repurchase program, according to a Saturday filing with the Shanghai bourse.

The drug company plans to repurchase between 100 million yuan and 200 million yuan of shares at 398 yuan apiece.

What else is happening in Asia?